Literature DB >> 18441342

Automated quantitative dose-response modeling and point of departure determination for large toxicogenomic and high-throughput screening data sets.

Lyle D Burgoon1, Timothy R Zacharewski.   

Abstract

Regulatory and homeland security agencies undertake safety and risk assessments to assess the potential hazards of radiation, chemical, biological, and pharmaceutical agents. By law, these assessments must be science-based to ensure public safety and environmental quality. These agencies use dose-response modeling and benchmark dose methods to identify points of departure across single end points elicited by the agent. Regulatory agencies have also begun to examine toxicogenomic data to identify novel biomarkers of exposure and assess potential toxicity. The ToxResponse Modeler streamlines analyses and point of departure (POD) calculations across hundreds of responses (e.g., differential gene expression, changes in metabolite levels) through an automated process capable of large-scale modeling and model selection. The application identifies the best-fit dose-response model utilizing particle swarm optimization and calculates the probabilistic POD. The application analyzed a publicly available 2,3,7,8-tetrachlorodibenzo-p-dioxin dose-response data set of hepatic gene expression data in C57BL/6 mice to identify putative biomarkers. The Gene Ontology mapped these responses to specific functions to differentiate adaptive effects from toxic responses. In principle, safety and risk assessors could use the automated ToxResponse Modeler to analyze any large dose-response data set including outputs from high-throughput screening assays to assist with the ranking and prioritization of compounds that warrant further investigation or development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18441342     DOI: 10.1093/toxsci/kfn083

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  18 in total

1.  Effects of TCDD on the expression of nuclear encoded mitochondrial genes.

Authors:  Agnes L Forgacs; Lyle D Burgoon; Scott G Lynn; John J LaPres; Timothy Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2010-04-24       Impact factor: 4.219

2.  2,3,7,8-Tetrachlorodibenzo-p-Dioxin Alters Lipid Metabolism and Depletes Immune Cell Populations in the Jejunum of C57BL/6 Mice.

Authors:  Kelly A Fader; Rance Nault; Dustin A Ammendolia; Jack R Harkema; Kurt J Williams; Robert B Crawford; Norbert E Kaminski; Dave Potter; Bonnie Sharratt; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2015-09-16       Impact factor: 4.849

3.  Comparative analysis of temporal and dose-dependent TCDD-elicited gene expression in human, mouse, and rat primary hepatocytes.

Authors:  Agnes L Forgacs; Edward Dere; Michelle M Angrish; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2013-02-15       Impact factor: 4.849

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin dose-dependently increases bone mass and decreases marrow adiposity in juvenile mice.

Authors:  Kelly A Fader; Rance Nault; Sandi Raehtz; Laura R McCabe; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2018-04-16       Impact factor: 4.219

5.  Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice.

Authors:  Anna K Kopec; Lyle D Burgoon; Daher Ibrahim-Aibo; Ashley R Burg; Andrea W Lee; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Jack R Harkema; J Craig Rowlands; Robert A Budinsky; Timothy R Zacharewski
Journal:  Toxicol Sci       Date:  2010-08-11       Impact factor: 4.849

6.  PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands.

Authors:  Anna K Kopec; Lyle D Burgoon; Daher Ibrahim-Aibo; Bryan D Mets; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-18       Impact factor: 4.219

7.  System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses.

Authors:  Brandi N Snyder-Talkington; Julian Dymacek; Dale W Porter; Michael G Wolfarth; Robert R Mercer; Maricica Pacurari; James Denvir; Vincent Castranova; Yong Qian; Nancy L Guo
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-08       Impact factor: 4.219

8.  New perspectives for in vitro risk assessment of multiwalled carbon nanotubes: application of coculture and bioinformatics.

Authors:  Brandi N Snyder-Talkington; Yong Qian; Vincent Castranova; Nancy L Guo
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2012       Impact factor: 6.393

9.  RNA-Seq versus oligonucleotide array assessment of dose-dependent TCDD-elicited hepatic gene expression in mice.

Authors:  Rance Nault; Kelly A Fader; Tim Zacharewski
Journal:  BMC Genomics       Date:  2015-05-10       Impact factor: 3.969

Review 10.  Current perspectives on the use of alternative species in human health and ecological hazard assessments.

Authors:  Edward J Perkins; Gerald T Ankley; Kevin M Crofton; Natàlia Garcia-Reyero; Carlie A LaLone; Mark S Johnson; Joseph E Tietge; Daniel L Villeneuve
Journal:  Environ Health Perspect       Date:  2013-06-14       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.